| The neutrophil-lymphocyte ratio and its relationship with insulin resistance in obesity S Karakaya, M Altay, FK Efe, İ Karadağ, O Ünsal, O Bulur, M Eser, ... Turkish Journal of Medical Sciences 49 (1), 245-248, 2019 | 45 | 2019 |
| The relationship between prognostic nutritional index and treatment response in patients with metastatic renal cell cancer HA Yasar, K Bir Yucel, C Arslan, G Ucar, S Karakaya, B Bilgin, H Taban, ... Journal of Oncology Pharmacy Practice 26 (5), 1110-1116, 2020 | 26 | 2020 |
| Renal function improves with the treatment of hypothyroidism O Bulur, K Dal, DT Ertugrul, M Eser, F Kaplan Efe, S Karakaya, K Şahin, ... Endocrine research 42 (3), 246-251, 2017 | 25 | 2017 |
| The effect of glycemic control on CEA, CA 19-9, amylase and lipase levels N Ata, K Dal, M Kucukazman, AÖ Yeniova, S Karakaya, O Unsal, ... Open Medicine 10 (1), 2014 | 19 | 2014 |
| Association of neutrophil-to-lymphocyte ratio and microalbuminuria in patients with normal eGFR AA Kutlugun, FA Ebinc, MT Ozturk, FK Efe, I Karadag, M Eser, O Unsal, ... Romanian Journal of Internal Medicine 56 (1), 21-26, 2018 | 17 | 2018 |
| Can neutrophil/lymphocyte ratio be used as an indicator of inflammation in patients with hyperthyroidism? M Dağdeviren, T Akkan, D Yapar, S Karakaya, T Dağdeviren, D Ertuğrul, ... Journal of Medical Biochemistry 39 (1), 7, 2020 | 15 | 2020 |
| The relationship between pan-immune-inflammation value and survival outcomes in patients with metastatic renal cell carcinoma treated with nivolumab in the second line and … E Yekedüz, D Tural, İ Ertürk, S Karakaya, C Erol, Ö Ercelep, Ç Arslan, ... Journal of Cancer Research and Clinical Oncology 148 (12), 3537-3546, 2022 | 14 | 2022 |
| Efficacy of subsequent treatments in patients with hormone-positive advanced breast cancer who had disease progression under CDK 4/6 inhibitor therapy C Karacin, B Oksuzoglu, A Demirci, M Keskinkılıç, NK Baytemür, F Yılmaz, ... BMC cancer 23 (1), 136, 2023 | 12 | 2023 |
| Prognostic value of the modified systemic inflammation score in non-small-cell lung cancer with brain metastasis F Wang, L Chen, Z Wang, Q Xu, H Huang, H Wang, X Li, M Yu, J Chen, ... Cancer Cell International 22 (1), 320, 2022 | 12 | 2022 |
| Trimester-specific reference intervals of thyroid function tests in Turkish pregnants O Bulur, Z Atak, DT Ertugrul, E Beyan, E Gunakan, S Karakaya, K Sahin, ... Gynecological Endocrinology 36 (5), 413-416, 2020 | 12 | 2020 |
| The relationship between systemic immune inflammation index and survival in patients with metastatic renal cell carcinomatreated withtyrosine kinase inhibitors KB Yücel, E Yekedüz, S Karakaya, D Tural, İ Ertürk, C Erol, Ö Ercelep, ... Scientific reports 12 (1), 16559, 2022 | 11 | 2022 |
| CROSS or FLOT in distal esophageal and gastroesophageal cancer I Karadag, S Karakaya, O Ates, OB Cakmak Oksuzoglu J Coll Physicians Surg Pak 31 (3), 326-9, 2021 | 9 | 2021 |
| Neutrophil–lymphocyte ratio as a prognostic factor for survival in patients with advanced renal cell carcinoma (Turkish Oncology Group Study) M Hizal, MAN Sendur, HA Yasar, K Bir Yucel, C Arslan, G Ucar, ... Journal of Oncology Pharmacy Practice 26 (7), 1583-1589, 2020 | 9 | 2020 |
| The role of insulin-like growth factor-1 on steatohepatitis K Dal, O Bulur, N Ata, AO Yeniova, S Baser, S Karakaya, O Unsal, ... Acta Gastro-Enterologica Belgica 80 (1), 21-24, 2017 | 9 | 2017 |
| The potential prognostic novel markers PIV and PILE score to predict survival outcomes at hepatocellular cancer. I Karadağ, S Karakaya, ME Yilmaz, ÖBÇ Öksüzoğlu European Review for Medical & Pharmacological Sciences 26 (20), 2022 | 7 | 2022 |
| Association of serum proprotein convertase Subtilisin/Kexin Type 9 (PCSK9) level with thyroid function disorders. AM Yildirim, AO Koca, E Beyan, O Dogan, S Karakaya, Z Aksoz, ... European Review for Medical & Pharmacological Sciences 25 (17), 2021 | 7 | 2021 |
| Hereditary breast-ovarian cancer and BRCA1/BRCA2 variants: a single center experience A Gezdirici, EG İli, B Değirmenci, AA Gümüş, G Özdemir, NA Erman, ... Acta Oncologica Turcica 54 (3), 264-272, 2021 | 6 | 2021 |
| Sunitinib or Pazopanib: Is There Any Difference Between Tyrosine Kinase Inhibitors in the Pre-Nivolumab Setting in Metastatic Renal Cell Carcinoma? G Ucar, Y Acikgoz, Y Ergun, O Bal, M Yilmaz, S Karakaya, N Akdeniz, ... Cureus 12 (9), 2020 | 6 | 2020 |
| Can neutrophil-to-lymphocyte ratio or platelet-to lymphocyte ratio predict chemotherapy response in testicular cancer S Karakaya, I Karadag, O Ates, OBC Oksuzoglu Eurasian J Med Investig 5, 269-73, 2021 | 5 | 2021 |
| High neutrophil-lymphocyte ratio, platelet-lymphocyte ratio and low lymphocyte levels are correlated with worse pathological complete response rates S Karakaya, İ Karadağ, ME Yılmaz, ÖBÇ Öksüzoğlu Cureus 14 (3), 2022 | 4 | 2022 |
